Vince P.A. van Reijmersdal

Vince P.A. van Reijmersdal

Auto-generated profile, based on publicly available information

Vince P.A. van Reijmersdal

Radboud University Medical Center 1 Department of Medical BioSciences Nijmegen

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2025 in Journal of Cell Biology
Verified
Journal Article
Open access
GFGuus A. Franken
Guus A. Franken
HWHarry Warner
Harry Warner
JCJorge Cuenca-Escalona
Jorge Cuenca-Escalona
ISIsabel F. Stehle
Isabel F. Stehle
VRVince P.A. van Reijmersdal
Vince P.A. van Reijmersdal
LCLaia Querol Cano
Laia Querol Cano
Adaptive immunity relies on dendritic cell (DC) migration to transport antigens from tissues to lymph nodes. Galectins, a family of β-galactoside–binding proteins, control cell membrane organization, exerting crucial roles in multiple physiological processes. Here, we report a novel mechanism underlying cell polarity and uropod retraction by demonstrating that galectin-9 regulates basal and chemokine-driven DC migration in humans and mice. Galectin-9 depletion caused a defect in RhoA signaling that resulted in impaired cell rear contractility. Mechanistically, galectin-9 interacts with and organizes CD44 at the cell surface, in turn modulating RhoA binding to GEF-H1 and the initiation of downstream signaling. Analysis of DC motility in the 3D tumor microenvironment revealed galectin-9 is also required for DC recruitment and infiltration. Exogenous galectin-9 rescued the motility of tumor-immunocompromised human blood DCs, validating the physiological relevance of galectin-9 in DC migration. Our results identify galectin-9 as a necessary mechanistic component for DC motility by regulating cell polarity and contractility, and underscore its implications for DC-based immunotherapies.